RCEL
AVITA Medical, Inc. NASDAQ Listed May 14, 2012$3.97
+1.28%
vs $3.92
Mkt Cap $110.6M
52w Low $3.27
20.1% of range
52w High $6.76
50d MA $4.29
200d MA $4.26
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
-0.1x
ROE
291.8%
P/FCF
-3.5x
RSI (14)
33.30
ATR (14)
$0.22
Beta
1.89
50d MA
$4.29
200d MA
$4.26
Avg Volume
330.0K
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
28159 Avenue Stanford · Valencia, CA 91355 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | AMC | -0.36 | -0.38 | -4.3% | 3.72 | -1.6% | +11.8% | +3.6% | +0.0% | +1.6% | +9.4% | — |
| Nov 6, 2025 | AMC | -0.43 | -0.46 | -7.0% | 3.40 | -0.9% | +10.9% | +5.3% | -0.3% | -4.5% | -1.1% | — |
| Aug 7, 2025 | AMC | -0.26 | -0.38 | -46.2% | 5.38 | -30.7% | -21.0% | +13.2% | +14.8% | +4.3% | +0.7% | — |
| May 8, 2025 | AMC | -0.39 | -0.53 | -35.9% | 9.33 | -22.3% | -25.3% | +4.0% | -3.3% | -4.6% | -4.8% | — |
| Feb 13, 2025 | AMC | -0.30 | -0.44 | -46.7% | 8.78 | +13.0% | +20.4% | -2.2% | -1.2% | -2.6% | -2.0% | — |
| Nov 7, 2024 | AMC | -0.42 | -0.62 | -47.6% | 12.40 | -3.2% | -3.6% | +2.1% | +3.8% | +1.7% | -2.3% | — |
| Aug 8, 2024 | AMC | -0.59 | -0.60 | -1.7% | 7.93 | +7.4% | +20.7% | +0.1% | +0.3% | -6.5% | +3.6% | — |
| May 13, 2024 | AMC | -0.26 | -0.73 | -180.8% | 8.35 | -4.9% | +4.4% | -6.0% | -3.4% | +4.4% | -1.2% | — |
| Feb 22, 2024 | AMC | -0.34 | -0.28 | +17.6% | 17.01 | -8.2% | +0.5% | +7.0% | +0.1% | -7.9% | +7.5% | — |
| Nov 9, 2023 | AMC | -0.53 | -0.34 | +35.8% | 9.88 | +21.5% | +14.3% | +10.7% | +7.4% | -3.8% | -2.6% | — |
| Aug 10, 2023 | AMC | -0.34 | -0.41 | -20.6% | 18.27 | +8.1% | +1.0% | -0.9% | -3.7% | -5.3% | -2.8% | — |
| May 11, 2023 | AMC | -0.22 | -0.37 | -68.2% | 15.72 | -1.2% | -23.0% | +4.4% | -3.9% | +0.3% | -3.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15 | Lake Street | Upgrade | Hold → Buy | $6 | $4.36 | $4.66 | +6.9% | +4.6% | -8.1% | +0.2% | +2.9% | +3.7% |
| Apr 9 | D. Boral Capital | Maintains | Buy → Buy | — | $4.10 | $4.13 | +0.7% | +10.7% | +10.4% | -2.0% | +14.1% | -7.9% |
| Apr 8 | D. Boral Capital | Maintains | Buy → Buy | — | $3.87 | $4.08 | +5.4% | +5.9% | +10.7% | +10.4% | -2.0% | +14.1% |
| Feb 17 | D. Boral Capital | Maintains | Buy → Buy | — | $4.16 | $4.15 | -0.2% | +3.6% | +0.0% | +1.6% | +9.4% | +1.3% |
| Jan 26 | D. Boral Capital | Maintains | Buy → Buy | — | $4.44 | $4.45 | +0.2% | +2.0% | +0.9% | -2.8% | -1.8% | +1.1% |
| Jan 16 | Lake Street | Maintains | Hold → Hold | — | $3.46 | $3.47 | +0.3% | +12.7% | -3.3% | +3.2% | +6.2% | +7.5% |
| Jan 15 | D. Boral Capital | Maintains | Buy → Buy | — | $3.52 | $3.50 | -0.6% | -1.7% | +12.7% | -3.3% | +3.2% | +6.2% |
| Nov 20 | BTIG | Upgrade | Sell → Neutral | — | $3.95 | $4.09 | +3.5% | -2.8% | -1.3% | -1.1% | +0.0% | +4.3% |
| Nov 7 | D. Boral Capital | Maintains | Buy → Buy | — | $3.40 | $3.37 | -0.9% | +10.9% | +5.3% | -0.3% | -4.5% | -1.1% |
| Oct 17 | D. Boral Capital | Maintains | Buy → Buy | — | $5.38 | $4.30 | -20.1% | -25.8% | +0.5% | +2.7% | -3.9% | +1.5% |
| Oct 17 | Lake Street | Downgrade | Buy → Hold | — | $5.38 | $4.30 | -20.1% | -25.8% | +0.5% | +2.7% | -3.9% | +1.5% |
| Sep 15 | D. Boral Capital | Maintains | Buy → Buy | — | $4.56 | $5.51 | +20.8% | +48.2% | -7.5% | -6.6% | -5.1% | -1.3% |
| Sep 5 | D. Boral Capital | Maintains | Buy → Buy | — | $4.29 | $4.30 | +0.2% | -0.7% | -1.2% | -0.5% | -0.5% | +5.0% |
| Aug 11 | Lake Street | Maintains | Buy → Buy | — | $4.25 | $4.43 | +4.2% | +13.2% | +14.8% | +4.3% | +0.7% | -2.9% |
| Aug 8 | D. Boral Capital | Maintains | Buy → Buy | — | $5.38 | $3.73 | -30.7% | -21.0% | +13.2% | +14.8% | +4.3% | +0.7% |
| Jun 10 | D. Boral Capital | Maintains | Buy → Buy | — | $6.11 | $6.16 | +0.8% | -2.0% | +1.2% | -4.3% | -4.5% | -1.3% |
| Jun 6 | D. Boral Capital | Maintains | Buy → Buy | — | $5.75 | $5.85 | +1.7% | +6.3% | +0.0% | -2.0% | +1.2% | -4.3% |
| Apr 10 | D. Boral Capital | Maintains | Buy → Buy | — | $8.71 | $8.67 | -0.5% | -0.9% | -0.1% | +3.8% | +3.1% | -2.3% |
| Apr 4 | D. Boral Capital | Maintains | Buy → Buy | — | $7.51 | $7.40 | -1.5% | -0.1% | +3.5% | -1.2% | +13.6% | -0.9% |
| Mar 18 | D. Boral Capital | Maintains | Buy → Buy | — | $9.03 | $9.00 | -0.3% | +2.4% | +5.0% | -4.4% | -3.4% | +4.0% |
| Feb 20 | D. Boral Capital | Maintains | Buy → Buy | — | $10.22 | $10.31 | +0.9% | -2.6% | -2.0% | -3.5% | +0.9% | +1.4% |
| Feb 14 | D. Boral Capital | Maintains | Buy → Buy | — | $8.78 | $9.92 | +13.0% | +20.4% | -2.2% | -1.2% | -2.6% | -2.0% |
| Jan 8 | Lake Street | Maintains | Buy → Buy | — | $14.06 | $10.27 | -27.0% | -36.4% | +2.2% | -3.5% | +0.8% | +0.3% |
| Jan 8 | D. Boral Capital | Maintains | Buy → Buy | — | $14.06 | $10.27 | -27.0% | -36.4% | +2.2% | -3.5% | +0.8% | +0.3% |
| Dec 24 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $11.75 | $12.93 | +10.0% | +9.9% | +2.0% | +2.4% | -2.1% | -3.1% |
| Nov 8 | Piper Sandler | Maintains | Neutral → Neutral | — | $12.40 | $12.00 | -3.2% | -3.6% | +2.1% | +3.8% | +1.7% | -2.3% |
| Aug 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $7.93 | $8.52 | +7.4% | +20.7% | +0.1% | +0.3% | -6.5% | +3.6% |
| May 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $8.35 | $7.94 | -4.9% | +4.4% | -6.0% | -3.4% | +4.4% | -1.2% |
| May 14 | Piper Sandler | Downgrade | Overweight → Neutral | — | $8.35 | $7.94 | -4.9% | +4.4% | -6.0% | -3.4% | +4.4% | -1.2% |
| Apr 11 | BTIG | Downgrade | Buy → Neutral | — | $14.44 | $12.28 | -15.0% | -28.3% | -4.5% | -4.3% | +2.5% | -3.3% |
| Feb 23 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $17.01 | $15.61 | -8.2% | +0.5% | +7.0% | +0.1% | -7.9% | +7.5% |
| Feb 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $17.01 | $15.61 | -8.2% | +0.5% | +7.0% | +0.1% | -7.9% | +7.5% |
| Jan 19 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $13.91 | $14.14 | +1.7% | +0.0% | +8.8% | -0.5% | +5.0% | +5.8% |
| Nov 21 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $12.54 | $11.05 | -11.9% | -18.9% | +3.2% | +2.2% | +1.1% | -0.7% |
| Nov 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $9.88 | $12.00 | +21.5% | +14.3% | +10.7% | +7.4% | -3.8% | -2.6% |
| Oct 19 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $10.02 | $9.97 | -0.5% | +0.4% | +1.3% | -0.2% | +0.3% | -2.4% |
| Sep 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $13.95 | $13.76 | -1.4% | -0.8% | +3.9% | +1.4% | +0.2% | -26.1% |
| Aug 22 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $16.19 | $16.34 | +0.9% | +1.0% | +2.3% | -3.8% | -0.9% | +1.7% |
| Aug 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $18.27 | $19.75 | +8.1% | +1.0% | -0.9% | -3.7% | -5.3% | -2.8% |
| Jul 28 | BofA Securities | Maintains | Buy → Buy | — | $18.25 | $19.02 | +4.2% | +13.9% | -2.6% | -2.3% | -4.5% | -1.2% |
| Jul 17 | Lake Street | Maintains | Buy → Buy | — | $20.59 | $20.62 | +0.1% | -0.6% | +1.0% | -4.1% | -7.7% | +2.8% |
| Jul 13 | Lake Street | Maintains | Buy → Buy | — | $17.27 | $17.74 | +2.7% | +20.4% | -1.0% | -0.6% | +1.0% | -4.1% |
| Jun 26 | Lake Street | Maintains | Buy → Buy | — | $16.20 | $15.92 | -1.7% | -3.0% | -0.3% | +5.9% | +5.4% | -2.7% |
| Jun 9 | Lake Street | Maintains | Buy → Buy | — | $16.55 | $16.69 | +0.8% | +3.4% | -1.5% | -2.0% | +0.5% | +2.3% |
| May 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $15.72 | $15.53 | -1.2% | -23.0% | +4.4% | -3.9% | +0.3% | -3.0% |
| May 12 | Lake Street | Maintains | Buy → Buy | — | $15.72 | $15.53 | -1.2% | -23.0% | +4.4% | -3.9% | +0.3% | -3.0% |
| Apr 17 | BTIG | Maintains | Buy → Buy | — | $15.74 | $16.00 | +1.7% | -2.0% | -2.9% | -2.8% | -1.6% | -0.1% |
| Feb 24 | Lake Street | Maintains | Buy → Buy | — | $9.06 | $10.75 | +18.7% | +36.5% | +6.5% | +1.8% | -1.9% | +4.3% |
| Mar 2 | Piper Sandler | Maintains | Overweight → Overweight | — | $21.49 | $22.95 | +6.8% | +6.8% | +2.1% | -6.6% | -9.9% | +5.6% |
| Nov 25 | BTIG | Maintains | Buy → Buy | — | $22.25 | $22.01 | -1.1% | -0.7% | +3.9% | -5.8% | -0.9% | +1.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Woody Joseph Fralin | — | Buy | 5,200 | $4.00 | $21K | 107,961 | -3.64% | +1.02% |
| Jun 9, 2026 | Woody Joseph Fralin | — | Buy | 5,000 | $4.20 | $21K | 97,761 | +0.00% | -0.25% |
| Jun 2, 2026 | Woody Joseph Fralin | — | Buy | 5,000 | $4.18 | $21K | 15,000 | +4.81% | +0.00% |
| Jun 1, 2026 | Woody Joseph Fralin | — | Buy | 5,000 | $4.34 | $22K | 5,000 | +4.81% | +0.00% |
| May 20, 2026 | O'Toole David D | CFO | Buy | 2,000 | $4.26 | $9K | 145,927 | +3.70% | +4.52% |
| May 19, 2026 | O'Toole David D | CFO | Buy | 2,000 | $4.24 | $8K | 143,927 | +2.86% | -1.18% |
8-K · 1.01
!! High
AVITA Medical, Inc. -- 8-K 1.01: Material Agreement
RCEL secured a $60 million credit agreement and guaranty, providing capital for operations and growth initiatives.
Jun 8
8-K · 5.02
!!! Very High
AVITA Medical, Inc. -- 8-K 5.02: Executive Change
Jun 4
8-K
Avita Medical, Inc. -- 8-K Filing
Avita Medical reported Q4 and full-year 2025 financial results, with the company continuing to advance its therapeutic acute wound care business across NASDAQ and ASX listings.
Feb 12
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Eversource Wealth Advisors, Llc | 102,535 | $10M | New | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 1,335,152 | $5M | New | Mar 2026 |
| 3 | Morgan Stanley | 299,430 | $1M | Added | Dec 2025 |
| 4 | Northern Trust Corp | 183,181 | $678K | Added | Mar 2026 |
| 5 | Divisadero Street Capital Management, Lp | 100,000 | $370K | — | Mar 2026 |
| 6 | Aqr Capital Management Llc | 94,361 | $349K | Reduced | Mar 2026 |
| 7 | Vanguard Portfolio Management Llc | 82,301 | $305K | New | Mar 2026 |
| 8 | Ubs Group Ag | 62,454 | $231K | Reduced | Mar 2026 |
| 9 | Bank Of America Corp /de/ | 62,128 | $230K | — | Mar 2026 |
| 10 | Marshall Wace, Llp | 52,562 | $194K | New | Mar 2026 |
| 11 | Strs Ohio | 47,700 | $165K | — | Dec 2025 |
| 12 | Nuveen, Llc | 42,389 | $157K | Added | Mar 2026 |
| 13 | Thompson Davis & Co., Inc. | 39,050 | $144K | New | Mar 2026 |
| 14 | Sanctuary Advisors, Llc | 24,095 | $123K | New | Sep 2025 |
| 15 | Bank Of New York Mellon Corp | 29,863 | $110K | — | Mar 2026 |
| 16 | Fmr Llc | 28,636 | $106K | Added | Mar 2026 |
| 17 | Citadel Advisors Llc | 25,624 | $95K | Added | Mar 2026 |
| 18 | Quantinno Capital Management Lp | 22,483 | $83K | New | Mar 2026 |
| 19 | Russell Investments Group, Ltd. | 18,471 | $68K | Added | Mar 2026 |
| 20 | Abel Hall, Llc | 16,810 | $62K | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$110.6M
Enterprise Value
$94.6M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.07x
P/B
—
P/S
1.53x
P/FCF
-3.55x
EV/EBITDA
—
Shares Out
27.9M
Financials (TTM)
Revenue
$72.3M
Net Income
-$45.3M
EBITDA
-$37.7M
Free Cash Flow
-$31.2M
Op Cash Flow
-$31.2M
EPS Basic
$-1.74
EPS Diluted
$-35.96
EPS Forward
$-1.00
Gross Margin
81.4%
Op Margin
-54.6%
Net Margin
-62.7%
Balance Sheet
Total Assets
$56.4M
Total Liab.
$73.0M
Total Equity
-$16.6M
Cash
$18.2M
LT Debt
$2.1M
Book Value/Sh
$-0.60
Debt/Equity
-0.13x
Current Ratio
0.57
Quick Ratio
0.46
Returns & Growth
ROE
291.8%
ROA
-86.2%
ROIC
667.2%
Rev Growth YoY
+11.5%
EPS Growth YoY
+27.2%
Price Returns
2W
-0.7%
1M
+0.2%
3M
-13.9%
6M
+17.0%
12M
-23.0%
Technicals
52W High
$6.76
52W Low
$3.27
50d MA
$4.29
200d MA
$4.26
RSI (14)
33.30
ATR (14)
$0.22
Beta
1.89
Avg Volume
330K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$6.75
High
$10.00
Low
$3.50
Median
$6.75
Data updated apr 26, 2026 10:03pm
· Source: financialmodelingprep.com